Capital at risk
Vision amid volatility
What companies are best placed to thrive in times of rapid change and increased uncertainty?
Disruption Week 2025
Discover the new industries, business models and growth strategies set to flourish in a world where old
certainties don’t apply.
In Disruption Week 2025, our investment managers share their thoughts and answer your questions about
the companies and themes in their sights.
Follow this link to see the answers to audience queries they didn’t manage to get to in the live sessions.
Discover the conversations
Scaling up in Silicon Valley and beyond
Join us for this Disruption Week webinar, where we delve into Silicon Valley’s unique ecosystem, exploring how Baillie Gifford’s investments in companies like Astera Labs and Twist Bioscience are driving technological and biotech innovation.
Catch up on 2024
Read up on last year’s topic: ‘new horizons of growth’
Insights
Our investment managers and specialists tell you about groundbreaking companies and other forces influencing their pursuit of growth.
Important information
Baillie Gifford Overseas Limited (ARBN 118 567 178) is registered as a foreign company under the Corporations Act 2001 (Cth) and holds Foreign Australian Financial Services Licence No 528911. The information in this area is provided to you on the basis that you are a “wholesale client” within the meaning of section 761G of the Corporations Act 2001 (Cth) (“Corporations Act”). Please advise Baillie Gifford Overseas Limited immediately if you are not a wholesale client. In no circumstances should the information in this area be made available to “retail clients” as defined by the Corporations Act.
The information in this area contains general information only. It does not take into account any person’s objectives, financial situation or needs.